American Clinical Laboratory v. Alex Azar, II
Court of Appeals for the D.C. Circuit
1Opinion of the Court
Pillard, Circuit Judge:
The Protecting Access to Medicare Act (PAMA, or the Act) seeks to align Medicare reimbursement rates for laboratory tests with rates paid for such tests in the private market. To enable the Secretary of Health and Human Services (HHS) to ascertain the private market's reimbursement rates, PAMA requires "applicable laboratories" to report private payor data to the Secretary that the Medicare program then uses to set new, presumably lower, Medicare reimbursement rates. The Secretary must implement the statute's definition of "applicable laboratory" before it can be used…
2Cases cited18 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- Trudeau v. Federal Trade CommissionCourt of Appeals for the D.C. Circuit · 2006
- Bowen v. Michigan Academy of Family PhysiciansSupreme Court of the United States · 1986
- Block v. Community Nutrition InstituteSupreme Court of the United States · 1984
13 more not listed; retrieve them via the Exa API.
3Cited by20 opinions
- North American Butterfly Association v. Chad F. WolfCourt of Appeals for the D.C. Circuit · 2020
- Make The Road New York v. Chad F. WolfCourt of Appeals for the D.C. Circuit · 2020
- Federal Express Corporation v. U.S. Department of CommerceCourt of Appeals for the D.C. Circuit · 2022
- Hemp Industries Association v. DEACourt of Appeals for the D.C. Circuit · 2022
- American Clinical Laboratory Association v. Xavier BecerraCourt of Appeals for the D.C. Circuit · 2022
15 more not listed; retrieve them via the Exa API.